Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

Levels of Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the COVID-19 Pandemic: A Cross-sectional Study

Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pain and comparisons and correlation analyses will be carried out.

Fibromyalgia is a generalized pain condition that is accompanied by sleep disturbances, anxiety, depression and somatic symptoms. During Coronavirus disease 2019 pandemic, fibromyalgia patients as well as the general population have increased anxiety levels. This study was planned to evaluate fibromyalgia patients' levels of coronavirus disease 2019 related resilience, anxiety, obsession levels about coronavirus disease 2019, quality of life and pain levels and compare them with healthy controls living in the same household.

Inclusion Criteria:

• Having a diagnosis of fibromyalgia according to the American college of rheumatology 2016 classification criteria
• Older than 18 years of age

Exclusion Criteria:

• Illiteracy
• A history of coronavirus disease 2019 infection in the last month
• Change in medication to treat fibromyalgia in the last 3 months
• Living alone (lack of a control subject)
• Severe neurological or psychiatric disorder that might hinder subjects' ability to answer the study questions